A

Atara Biotherapeutics
D

ATRA

11.940
USD
0.19
(1.62%)
مغلق
حجم التداول
1,164
الربح لكل سهم
1
العائد الربحي
-
P/E
17
حجم السوق
83,855,002
أصول ذات صلة
C
CRVS
0.57000
(11.74%)
5.42500 USD
F
FATE
0.00000
(0.00%)
1.08000 USD
R
RCKT
0.01500
(0.50%)
3.04500 USD
R
RGEN
-2.350
(-1.86%)
124.320 USD
T
TXG
0.110
(0.83%)
13.360 USD
V
VKTX
-0.230
(-0.57%)
40.030 USD
المزيد
الأخبار المقالات

العنوان: Atara Biotherapeutics Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).